104 related articles for article (PubMed ID: 8347343)
21. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma.
Olivera A; Edsall L; Poulton S; Kazlauskas A; Spiegel S
FASEB J; 1999 Sep; 13(12):1593-600. PubMed ID: 10463951
[TBL] [Abstract][Full Text] [Related]
22. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Fantl WJ; Williams LT
Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
[TBL] [Abstract][Full Text] [Related]
23. Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma.
Tiesman J; Hart CE
J Biol Chem; 1993 May; 268(13):9621-8. PubMed ID: 8486649
[TBL] [Abstract][Full Text] [Related]
24. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation.
Bornfeldt KE; Raines EW; Graves LM; Skinner MP; Krebs EG; Ross R
Ann N Y Acad Sci; 1995 Sep; 766():416-30. PubMed ID: 7486687
[TBL] [Abstract][Full Text] [Related]
25. A functional soluble extracellular region of the platelet-derived growth factor (PDGF) beta-receptor antagonizes PDGF-stimulated responses.
Duan DS; Pazin MJ; Fretto LJ; Williams LT
J Biol Chem; 1991 Jan; 266(1):413-8. PubMed ID: 1845970
[TBL] [Abstract][Full Text] [Related]
26. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
27. Chimeric alpha- and beta-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the alpha-PDGF receptor that determine PDGF-AA binding specificity.
Heidaran MA; Pierce JH; Jensen RA; Matsui T; Aaronson SA
J Biol Chem; 1990 Nov; 265(31):18741-4. PubMed ID: 2172231
[TBL] [Abstract][Full Text] [Related]
28. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells.
Choudhury GG; Grandaliano G; Jin DC; Katz MS; Abboud HE
Kidney Int; 2000 Mar; 57(3):908-17. PubMed ID: 10720944
[TBL] [Abstract][Full Text] [Related]
29. PLC-gamma activation is required for PDGF-betaR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells.
Alimandi M; Heidaran MA; Gutkind JS; Zhang J; Ellmore N; Valius M; Kazlauskas A; Pierce JH; Li W
Oncogene; 1997 Jul; 15(5):585-93. PubMed ID: 9247312
[TBL] [Abstract][Full Text] [Related]
30. Role of immunoglobulin-like domains 2-4 of the platelet-derived growth factor alpha-receptor in ligand-receptor complex assembly.
Miyazawa K; Bäckström G; Leppänen O; Persson C; Wernstedt C; Hellman U; Heldin CH; Ostman A
J Biol Chem; 1998 Sep; 273(39):25495-502. PubMed ID: 9738020
[TBL] [Abstract][Full Text] [Related]
31. Conservation in sequence and affinity of human and rodent PDGF ligands and receptors.
Herren B; Weyer KA; Rouge M; Lötscher P; Pech M
Biochim Biophys Acta; 1993 Jun; 1173(3):294-302. PubMed ID: 8318539
[TBL] [Abstract][Full Text] [Related]
32. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
Chen YC; Chang CN; Hsu HC; Chiou SJ; Lee LT; Hseu TH
Life Sci; 2009 Jun; 84(25-26):915-22. PubMed ID: 19393247
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.
Yates AJ; VanBrocklyn J; Saqr HE; Guan Z; Stokes BT; O'Dorisio MS
Exp Cell Res; 1993 Jan; 204(1):38-45. PubMed ID: 8416794
[TBL] [Abstract][Full Text] [Related]
34. Control of meningioma cell growth by platelet-derived growth factor (PDGF).
Mauro A; Di Sapio A; Mocellini C; Schiffer D
J Neurol Sci; 1995 Aug; 131(2):135-43. PubMed ID: 7595638
[TBL] [Abstract][Full Text] [Related]
35. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
Spacey GD; Uings IJ; Slater M; Hirst S; Bonser RW
Biochem Pharmacol; 1998 Feb; 55(3):261-71. PubMed ID: 9484791
[TBL] [Abstract][Full Text] [Related]
36. Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors.
Paulsson Y; Karlsson C; Heldin CH; Westermark B
J Cell Physiol; 1993 Oct; 157(1):97-103. PubMed ID: 8408247
[TBL] [Abstract][Full Text] [Related]
37. Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin.
Schilling D; Reid IV JD; Hujer A; Morgan D; Demoll E; Bummer P; Fenstermaker RA; Kaetzel DM
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):637-44. PubMed ID: 9677323
[TBL] [Abstract][Full Text] [Related]
38. Viability of transgenic mice expressing a platelet derived growth factor (PDGF) antagonist in plasma.
Liao X; Escobedo JA; Williams LT
J Investig Med; 1996 Apr; 44(4):139-43. PubMed ID: 8689409
[TBL] [Abstract][Full Text] [Related]
39. Ligand-induced interaction between alpha- and beta-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation.
Kanakaraj P; Raj S; Khan SA; Bishayee S
Biochemistry; 1991 Feb; 30(7):1761-7. PubMed ID: 1847074
[TBL] [Abstract][Full Text] [Related]
40. Detection of activated platelet-derived growth factor receptors in human meningioma.
Shamah SM; Alberta JA; Giannobile WV; Guha A; Kwon YK; Carroll RS; Black PM; Stiles CD
Cancer Res; 1997 Sep; 57(18):4141-7. PubMed ID: 9307305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
